[Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol].
Reginster
J Y
JY
Sarlet
N
N
Deroisy
R
R
Denis
D
D
Lecart
M P
MP
Franchimont
P
P
D000279:Administration, Cutaneous; D000284:Administration, Oral; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D004958:Estradiol / Q000008:administration & dosage*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control*
D004966:Estrogens, Conjugated (USP); D004958:Estradiol
Comparaison de l'effet ostéoprotecteur des oestrogènes conjugués équins administrés par voie orale et du 17 beta-oestradiol percutané.